These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3488347)
21. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B. Peterson LB; Wilner GD; Thomas DW J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245 [TBL] [Abstract][Full Text] [Related]
22. Glucose, pyruvate, and lactate concentrations in the blastocoel cavity of rat and mouse embryos. Brison DR; Hewitson LC; Leese HJ Mol Reprod Dev; 1993 Jul; 35(3):227-32. PubMed ID: 8352926 [TBL] [Abstract][Full Text] [Related]
23. Activation of nonspecific killer cells by interleukin 2-containing supernatants. Teh HS; Yu M J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216 [TBL] [Abstract][Full Text] [Related]
24. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224 [TBL] [Abstract][Full Text] [Related]
25. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
26. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response. Schirrmacher V; Landolfo S; Zawatzky R; Kirchner H Invasion Metastasis; 1981; 1(3):175-94. PubMed ID: 6821364 [TBL] [Abstract][Full Text] [Related]
27. Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2. Finke JH; Scott J; Gillis S; Hilfiker ML J Immunol; 1983 Feb; 130(2):763-7. PubMed ID: 6600253 [TBL] [Abstract][Full Text] [Related]
28. Cell surface glycoprotein differences between a highly malignant murine tumor line and a plastic-adherent, less malignant variant. Lang E; Altevogt P; Schirrmacher V Cancer Detect Prev Suppl; 1987; 1():73-9. PubMed ID: 3480072 [TBL] [Abstract][Full Text] [Related]
29. Effects of cholera toxin on the lymphoid system. III. In vivo generation of cytotoxic lymphocytes. Tsuru S; Nomoto K; Oka M; Zinnaka Y J Clin Lab Immunol; 1983 Apr; 10(4):209-14. PubMed ID: 6602889 [TBL] [Abstract][Full Text] [Related]
30. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones. Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090 [TBL] [Abstract][Full Text] [Related]
31. Establishment of three PPD-reactive helper T cell clones with distinct functions in B cell activation. Sano Y; Yamada G; Dobashi K; Mizuochi T; Hamaoka T; Takatsu K J Immunol; 1984 Aug; 133(2):629-35. PubMed ID: 6234353 [TBL] [Abstract][Full Text] [Related]
32. Antigen-independent activation of memory cytotoxic T cells by interleukin 2. Lefrancois L; Klein JR; Paetkau V; Bevan MJ J Immunol; 1984 Apr; 132(4):1845-50. PubMed ID: 6230394 [TBL] [Abstract][Full Text] [Related]
33. Dacarbazine-induced immunogenicity of a murine leukemia is attenuated in cells transfected with mutated K-ras gene. Testorelli C; Bussini S; De Filippi R; Marelli O; Orlando L; Greiner JW; Grohmann U; Tentori L; Giuliani A; Bonmassar E; Graziani G J Exp Clin Cancer Res; 1997 Mar; 16(1):15-22. PubMed ID: 9148855 [TBL] [Abstract][Full Text] [Related]
34. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors. Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785 [TBL] [Abstract][Full Text] [Related]
35. Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor. Grohmann U; Puccetti P; Belladonna ML; Fallarino F; Bianchi R; Binaglia L; Sagakuchi K; Mage MG; Appella E; Fioretti MC J Immunol; 1995 May; 154(9):4630-41. PubMed ID: 7722315 [TBL] [Abstract][Full Text] [Related]
36. Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice. Trainer DL; Wheelock EF Cancer Res; 1984 Jul; 44(7):2897-906. PubMed ID: 6609767 [TBL] [Abstract][Full Text] [Related]
37. Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses. Wolos JA; Frondorf KA; Babcock GF; Stripp SA; Bowlin TL Cell Immunol; 1993 Jul; 149(2):402-8. PubMed ID: 8330316 [TBL] [Abstract][Full Text] [Related]
38. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus. Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834 [TBL] [Abstract][Full Text] [Related]
39. Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice. Robinson MK; Truitt GA; Okayasu T; Wheelock EF Cancer Res; 1983 Dec; 43(12 Pt 1):5831-6. PubMed ID: 6227383 [TBL] [Abstract][Full Text] [Related]
40. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse. Margenthaler JA; Flye MW J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]